Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study

Lucile Musset (1) , Yves Allenbach (2) , Olivier Benveniste (2) , Olivier Boyer (3) , Xavier Bossuyt , Chelsea Bentow , Joe Phillips , Andrew Mammen (4) , Philip van Damme (5) , René Westhovens , Anna Ghirardello , Andrea Doria , May Choi , Marvin Fritzler , Heinrike Schmeling , Yoshinao Muro , Ignacio García-de La Torre , Miguel Ortiz-Villalvazo , Nicola Bizzaro , Maria Infantino , Tiziana Imbastaro , Qinglin Peng , Guochun Wang , Jiří Vencovský (6) , Martin Klein , Olga Krystufkova , Franco Franceschini , Micaela Fredi , Sophie Hue (7) , Thibaut Belmondo , Katalin Danko , Michael Mahler (8)

1 CHU Pitié-Salpêtrière [AP-HP]
2 Thérapie des maladies du muscle strié
3 Physiopathologie et biothérapies des maladies inflammatoires et autoimmunes
4 NIH - National Institutes of Health [Bethesda, MD, USA]
5 KU Leuven - Catholic University of Leuven = Katholieke Universiteit Leuven
6 Institute of Rheumatology
7 IMRB - Institut Mondor de Recherche Biomédicale
8 INOVA Diagnostics, San Diego

Domaines: Sciences du Vivant [q-bio]; Immunologie

Lucile Musset, Yves Allenbach, Olivier Benveniste, Olivier Boyer, Xavier Bossuyt, et al.. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study. Autoimmunity Reviews, 2016, 15 (10), pp.983-993. ⟨10.1016/j.autrev.2016.07.023⟩. ⟨hal-02377492⟩